CEBIOTEX

CEBIOTEX, based in Barcelona, Spain, is a biotechnology company. Cebiotex is a biotechnology company that uses proprietary nanofibre engineering to deliver anti-tumour agents directly at surgical sites for local, post-surgical cancer therapy. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing CEB-01 in pancreatic ductal adenocarcinoma. The largest, NCT06986811 (CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours), plans to enrol 60 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.